Zobrazeno 1 - 10
of 43
pro vyhledávání: '"M M, Tomasiak"'
Autor:
Ewa Chabielska, M. M. Tomasiak-Lozowska, Agata Golaszewska, Tomasz Rusak, Marta Iwanicka, Agnieszka Leszczynska, Natalia Marcinczyk, Tomasz Misztal
Publikováno v:
Free Radical Biology and Medicine. 141:426-437
Hypochlorite (HOCl), a strong oxidant and antimicrobial agent, has been proposed to be associated with hemostatic abnormalities during inflammatory response. However, its complex impact on hemostasis is not completely understood. In this report we st
Autor:
Tadech Boonpiyathad, Andrzej Eljaszewicz, Milena Sokolowska, Norbert Meyer, Oliver F. Wirz, W. van de Veen, M. M. Tomasiak-Lozowska, Marcin Moniuszko, Kiat Ruxrungtham, Anna Bodzenta-Lukaszyk
Publikováno v:
Allergy. 72:407-415
Background The involvement of B cells in allergen tolerance induction remains largely unexplored. This study investigates the role of B cells in this process, by comparing B-cell responses in allergic patients before and during allergen immunotherapy
Autor:
Tomasz Misztal, Tomasz Rusak, M. M. Tomasiak-Lozowska, Justyna Brańska-Januszewska, Anna Bodzenta-Lukaszyk, Marian Tomasiak
Publikováno v:
Allergy. 72(2)
The aim of this study was to assess whether steroid-naive asthma modulates hemostasis. We evaluated the clot retraction rate (CRR), fibrinolysis rate (FR), clot density (CD) (by confocal microscopy), plasma levels of plasminogen activator inhibitor (
Autor:
Marian Tomasiak, Anna Bodzenta-Lukaszyk, Tomasz Misztal, Tomasz Rusak, M. M. Tomasiak-Lozowska
Publikováno v:
The Journal of asthma : official journal of the Association for the Care of Asthma. 53(6)
Asthma enhances the risk of pulmonary embolism. The mechanism of this phenomenon is unclear.We evaluated the kinetics of clot formation, clot retraction rate (CRR), clot volume at 40 min, the rate of lactate production (a marker of aerobic glycolysis
Autor:
Anna Bodzenta-Lukaszyk, Roman Skiepko, M. M. Tomasiak-Lozowska, Ziemowit Zietkowski, Danuta Lenczewska
Publikováno v:
International Archives of Allergy and Immunology. 154:25-32
Background: Omalizumab is a humanized monoclonal anti-IgE antibody developed for the treatment of IgE-mediated diseases, including asthma. The aim of the study was to determine the effect of omalizumab treatment on changes in RANTES in exhaled breath
Autor:
Ziemowit Zietkowski, Barbara Mroczko, Anna Bodzenta-Lukaszyk, Maciej Szmitkowski, M. M. Tomasiak-Lozowska, Roman Skiepko
Publikováno v:
Respiration. 80:463-471
Background: Exercise-induced bronchoconstriction (EIB) is a highly prevalent condition, whose pathophysiology is not well understood. Endothelins are proinflammatory, profibrotic, bronchoand vasoconstrictive peptides which play an important role in t
Autor:
Ziemowit Zietkowski, Barbara Mroczko, Maciej Szmitkowski, M. M. Tomasiak-Lozowska, Anna Bodzenta-Lukaszyk, Roman Skiepko
Publikováno v:
Respiratory Medicine. 103:379-385
Summary Background Asthma is a chronic airway inflammatory disease. Measurement of serum high- sensitivity C-reactive protein (hs-CRP) levels has suggested the involvement of low-grade systemic inflammation in several disorders, such as cardiovascula
Publikováno v:
Journal of investigational allergologyclinical immunology. 23(3)
Publikováno v:
Journal of investigational allergologyclinical immunology. 21(7)
Allergic rhinitis is a chronic inflammatory disease induced by an immunoglobulin (Ig) E-mediated reaction after exposure to an allergen. Many patients with allergic rhinitis and no clinical evidence of asthma show a heightened response to histamine.T
Publikováno v:
Advances in medical sciences. 56(2)
Purpose The central role of IgE in allergic inflammation in asthma has provided a rationale for the development of omalizumab, the humanized monoclonal anti-IgE antibody. The aim of the study was to determine the effect of omalizumab treatment on cha